Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2014

Open Access 01-12-2014 | Research article

Two-stage hip revision arthroplasty with a hexagonal modular cementless stem in cases of periprosthetic infection

Authors: Ralf Dieckmann, Dino Schulz, Georg Gosheger, Karsten Becker, Kiriakos Daniilidis, Arne Streitbürger, Jendrik Hardes, Steffen Hoell

Published in: BMC Musculoskeletal Disorders | Issue 1/2014

Login to get access

Abstract

Background

Two-stage revision arthroplasty is today regarded as the gold standard treatment method for deep prosthetic joint infection. The aim of the present study was to evaluate clinical and functional outcomes with the Modular Universal Tumor And Revision System (MUTARS) RS stem in patients undergoing two-stage revisions.

Methods

The functional and clinical outcomes for 43 patients who had undergone two-stage revision procedures for PJI were analyzed in a retrospective study. The minimum follow-up period was 24 months. Shorter follow-up periods were only observed when there were complications such as loosening or recurrent infection. The mean follow-up period was 3.86 years (range 7 months to 11.6 years).

Results

The success rate with infection control for PJI was 93%. Reinfection occurred in four cases (7%). The risk of reinfection after MRSA infection was 20.5 times greater (P >0.01) than with sensitive or unknown bacteria. Two aseptic loosening occurred after 7 and 20 months. The average Harris Hip Score was 80 (range 62–93).

Conclusion

This retrospective study showed a 93% rate of eradication using specific antibiotic therapy. With the modular MUTARS RS stem, there was a low rate of aseptic loosening of 4.6%. MRSA infection was identified as a risk factor for reinfection. The two-stage procedure with modular cementless implants used is therefore appropriate for treating periprosthetic infections associated with hip endoprostheses.
Appendix
Available only for authorised users
Literature
1.
Gemeinsamer Bundesausschuss: Hüftendoprothesenversorgung Abschlussbericht 2010. 2012, Aqua - Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen
2.
Jamsen E, Furnes O, Engesaeter LB, Konttinen YT, Odgaard A, Stefansdottir A, Lidgren L: Prevention of deep infection in joint replacement surgery. Acta Orthop. 2010, 81: 660-666. 10.3109/17453674.2010.537805.CrossRefPubMedPubMedCentral
3.
Wilson J, Charlett A, Leong G, McDougall C, Duckworth G: Rates of surgical site infection after hip replacement as a hospital performance indicator: analysis of data from the English mandatory surveillance system. Infect Control Hosp Epidemiol. 2008, 29: 219-226. 10.1086/527511.CrossRefPubMed
4.
Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med. 2004, 351: 1645-1654. 10.1056/NEJMra040181.CrossRefPubMed
5.
Fink B, Grossmann A, Fuerst M, Schafer P, Frommelt L: Two-stage cementless revision of infected hip endoprostheses. Clin Orthop Relat Res. 2009, 467: 1848-1858. 10.1007/s11999-008-0611-y.CrossRefPubMed
6.
Haddad FS, Muirhead-Allwood SK, Manktelow AR, Bacarese-Hamilton I: Two-stage uncemented revision hip arthroplasty for infection. J Bone Joint Surg. 2000, British volume 82: 689-694.CrossRef
7.
Duncan CP, Masri BA: The role of antibiotic-loaded cement in the treatment of an infection after a hip replacement. Instr Course Lect. 1995, 44: 305-313.PubMed
8.
Estok DM, Harris WH: Long-term results of cemented femoral revision surgery using second-generation techniques. An average 11.7-year follow-up evaluation. Clin Orthop Relat Res. 1994, 299: 190-202.PubMed
9.
Kim YH, Kim JS, Park JW, Joo JH: Cementless revision for infected total hip replacements. J Bone Joint Surg. 2011, British volume 93: 19-26.CrossRef
10.
Della Valle CJ, Shuaipaj T, Berger RA, Rosenberg AG, Shott S, Jacobs JJ, Galante JO: Revision of the acetabular component without cement after total hip arthroplasty. A concise follow-up, at fifteen to nineteen years, of a previous report. J Bone Joint Surg. 2005, American Volume 87: 1795-1800.CrossRef
11.
Weeden SH, Paprosky WG: Minimal 11-year follow-up of extensively porous-coated stems in femoral revision total hip arthroplasty. J Arthroplasty. 2002, 17: 134-137. 10.1054/arth.2002.32461.CrossRefPubMed
12.
Fehring TK, Calton TF, Griffin WL: Cementless fixation in 2-stage reimplantation for periprosthetic sepsis. J Arthroplasty. 1999, 14: 175-181. 10.1016/S0883-5403(99)90122-5.CrossRefPubMed
13.
Hofmann AA, Goldberg TD, Tanner AM, Cook TM: Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty. 2005, 20: 874-879. 10.1016/j.arth.2004.12.055.CrossRefPubMed
14.
Koo KH, Yang JW, Cho SH, Song HR, Park HB, Ha YC, Chang JD, Kim SY, Kim YH: Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty. 2001, 16: 882-892. 10.1054/arth.2001.24444.CrossRefPubMed
15.
Kraay MJ, Goldberg VM, Fitzgerald SJ, Salata MJ: Cementless two-staged total hip arthroplasty for deep periprosthetic infection. Clin Orthop Relat Res. 2005, 441: 243-249. 10.1097/01.blo.0000194312.97098.0a.CrossRefPubMed
16.
Macheras GA, Koutsostathis SD, Kateros K, Papadakis S, Anastasopoulos P: A two stage re-implantation protocol for the treatment of deep periprosthetic hip infection. Mid to long-term results. Hip Int. 2012, 22 (Suppl 8): S54-S61.CrossRefPubMed
17.
Neumann DR, Hofstaedter T, List C, Dorn U: Two-stage cementless revision of late total hip arthroplasty infection using a premanufactured spacer. J Arthroplasty. 2012, 27: 1397-1401. 10.1016/j.arth.2011.10.022.CrossRefPubMed
18.
Valle CJ, Paprosky WG: Classification and an algorithmic approach to the reconstruction of femoral deficiency in revision total hip arthroplasty. J Bone Joint Surg. 2003, American volume 85-A (Suppl 4): 1-6.
19.
Harris WH: Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg. 1969, American volume 51: 737-755.
20.
Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008, 36: 309-332. 10.1016/j.ajic.2008.03.002.CrossRefPubMed
21.
Gebert C, Wessling M, Gotze C, Gosheger G, Hardes J: The Modular Universal Tumour and Revision System (MUTARS(R)) in endoprosthetic revision surgery. Int Orthop. 2010, 34: 1261-1265. 10.1007/s00264-010-1007-7.CrossRefPubMedPubMedCentral
22.
Anagnostakos K, Furst O, Kelm J: Antibiotic-impregnated PMMA hip spacers: current status. Acta Orthop. 2006, 77: 628-637. 10.1080/17453670610012719.CrossRefPubMed
23.
Cooper HJ, Della Valle CJ: The two-stage standard in revision total hip replacement. Bone Joint J. 2013, 95-B: 84-87. 10.1302/0301-620X.95B11.32906.CrossRefPubMed
24.
Masri BA, Panagiotopoulos KP, Greidanus NV, Garbuz DS, Duncan CP: Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplasty. 2007, 22: 72-78. 10.1016/j.arth.2006.02.156.CrossRefPubMed
25.
Nestor BJ, Hanssen AD, Ferrer-Gonzalez R, Fitzgerald RH: The use of porous prostheses in delayed reconstruction of total hip replacements that have failed because of infection. J Bone Joint Surg. 1994, American volume 76: 349-359.
26.
Wilson MG, Dorr LD: Reimplantation of infected total hip arthroplasties in the absence of antibiotic cement. J Arthroplasty. 1989, 4: 263-269. 10.1016/S0883-5403(89)80023-3.CrossRefPubMed
27.
Bohm P, Bischel O: Femoral revision with the Wagner SL revision stem: evaluation of one hundred and twenty-nine revisions followed for a mean of 4.8 years. J Bone Joint Surg. 2001, American volume 83-A: 1023-1031.
28.
Hedley AK, Gruen TA, Ruoff DP: Revision of failed total hip arthroplasties with uncemented porous-coated anatomic components. Clin Orthop Relat Res. 1988, 235: 75-90.PubMed
29.
Mcinnis DP, Horne G, Devane PA: Femoral revision with a fluted, tapered, modular stem seventy patients followed for a mean of 3.9 years. J Arthroplasty. 2006, 21: 372-380. 10.1016/j.arth.2005.08.022.CrossRefPubMed
30.
Paprosky WG, Greidanus NV, Antoniou J: Minimum 10-year-results of extensively porous-coated stems in revision hip arthroplasty. Clin Orthop Relat Res. 1999, 369: 230-242.CrossRefPubMed
31.
Colyer RA, Capello WN: Surgical treatment of the infected hip implant. Two-stage reimplantation with a one-month interval. Clin Orthop Relat Res. 1994, 298: 75-79.PubMed
32.
33.
Garvin KL, Evans BG, Salvati EA, Brause BD: Palacos gentamicin for the treatment of deep periprosthetic hip infections. Clin Orthop Relat Res. 1994, 298: 97-105.PubMed
34.
Leunig M, Chosa E, Speck M, Ganz R: A cement spacer for two-stage revision of infected implants of the hip joint. Int Orthop. 1998, 22: 209-214. 10.1007/s002640050244.CrossRefPubMedPubMedCentral
35.
Mcdonald DJ, Fitzgerald RH, Ilstrup DM: Two-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg. 1989, American volume 71: 828-834.
36.
Kuzyk PR, Dhotar HS, Sternheim A, Gross AE, Safir O, Backstein D: Two-stage revision arthroplasty for management of chronic periprosthetic hip and knee infection: techniques, controversies, and outcomes. J Am Acad Orthop Surg. 2014, 22: 153-164. 10.5435/JAAOS-22-03-153.CrossRefPubMed
37.
Zimmerli W: Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best practice & research. Clin Rheumatol. 2006, 20: 1045-1063.
38.
Bjerke-Kroll BT, Christ AB, Mclawhorn AS, Sculco PK, Jules-Elysee KM, Sculco TP: Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile. J Arthroplasty. 2014, 29: 877-882. 10.1016/j.arth.2013.09.053.CrossRefPubMed
39.
Jackson WO, Schmalzried TP: Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res. 2000, 381: 101-105.CrossRefPubMed
40.
Kilgus DJ, Howe DJ, Strang A: Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res. 2002, 404: 116-124.CrossRefPubMed
41.
Lim SJ, Park JC, Moon YW, Park YS: Treatment of periprosthetic hip infection caused by resistant microorganisms using 2-stage reimplantation protocol. J Arthroplasty. 2009, 24: 1264-1269. 10.1016/j.arth.2009.05.012.CrossRefPubMed
42.
Wirtz DC, Niethard FU: Etiology, diagnosis and therapy of aseptic hip prosthesis loosening–a status assessment. Zeitschrift fur Orthopadie und ihre Grenzgebiete. 1997, 135: 270-280. 10.1055/s-2008-1039388.CrossRefPubMed
43.
Dohmae Y, Bechtold JE, Sherman RE, Puno RM, Gustilo RB: Reduction in cement-bone interface shear strength between primary and revision arthroplasty. Clin Orthop Relat Res. 1988, 236: 214-220.PubMed
44.
Cordero-Ampuero J, De Dios M: What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties?. Clin Orthop Relat Res. 2010, 468: 3268-3277. 10.1007/s11999-010-1411-8.CrossRefPubMedPubMedCentral
45.
Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR: Risk factors for prosthetic joint infection: case–control study. Clin Infect Dis. 1998, 27: 1247-1254. 10.1086/514991.CrossRefPubMed
46.
Trampuz A, Zimmerli W: New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs. 2005, 6: 185-190.PubMed
Metadata
Title
Two-stage hip revision arthroplasty with a hexagonal modular cementless stem in cases of periprosthetic infection
Authors
Ralf Dieckmann
Dino Schulz
Georg Gosheger
Karsten Becker
Kiriakos Daniilidis
Arne Streitbürger
Jendrik Hardes
Steffen Hoell
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2014
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-15-398

Other articles of this Issue 1/2014

BMC Musculoskeletal Disorders 1/2014 Go to the issue

Research article

Development and validation of a Spanish translation of the Yale activity questionnaire

Research article

Quality of life after volar locked plating: a 10-year follow-up study of patients with intra-articular distal radius fractures

Research article

Assessment of the normal and pathological alignment of the elbow in children using the trochleocapitellar index

Study protocol

Preventing functional loss during immobilization after osteoporotic wrist fractures in elderly patients: a randomized clinical trial

Research article

The discriminative ability of FRAX, the WHO algorithm, to identify women with prevalent asymptomatic vertebral fractures: a cross-sectional study

Research article

Increased CCL19 and CCL21 levels promote fibroblast ossification in ankylosing spondylitis hip ligament tissue